Abstract: This disclosure includes back pattern counter measures for solid state drives. Embodiments described herein include setting and applying read threshold offsets according to flags set based on an amount of data stored within a memory block (e.g., an “openness” of the block). The flag is implemented during read commands to account for shifts in voltage distribution of open blocks. A value of the flag may be chosen based on a number of word lines included in the block that store data. The read threshold offsets may further be based on at least one of the set flag or an age of a respective NAND cell.

Abstract: A method for determining phase locking of critical arc light includes: step 1: monitoring and collecting light radiation intensity of an arc inside a switch cabinet in real time, and converting the collected light radiation intensity into an electrical signal; step 2: extracting a power-frequency fundamental wave of the electrical signal, comparing an amplitude of the power-frequency fundamental wave of the electrical signal with a first threshold, and generating a pre-warning signal based on a comparison result of the first threshold; step 3: comparing the amplitude of the power-frequency fundamental wave of the electrical signal with a second threshold voltage, and generating a control signal based on a comparison result of the second threshold voltage and a protection time threshold; and step 4: protecting the switch cabinet under the critical arc light environment based on the pre-warning signal and the control signal.

Abstract: Provided is a peptide compound comprising the amino acid sequence: G-W-Lys-X1-Ser-U-X2-Y-Z-Q wherein: G represents an optional N-terminal a 3,4-dihydrocinnamic acid group; W represents Ala or Ser, or is absent; U represents Tyr, DOPA or a single bond; X1 and X2 independently represent Pro, Hyp or diHyp; Y represents a single bond or represents a 1 to 5 amino acid sequence, in which the amino acids are selected from one or more of the group Pro, Hyp, diHyp, Thr, DOPA and Tyr; Z represents Pro, Hyp, diHyp, Thr, DOPA or Tyr; and Q represents Lys or is absent, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide compound, provided that when G is not present, W represents Ala or is absent and Q represents Lys, then Z represents Pro, Hyp, diHyp or Thr.

Abstract: A light emitting plate, a wiring plate and a display device are provided. The light emitting plate includes light emitting units. Each light emitting unit includes a light emitting sub-unit including a connection line unit and a light emitting diode chip connected with the connection line unit. The connection line unit includes electrical contact pairs, and each electrical contact pairs includes a first electrode contact and a second electrode contact; in each connection line unit, the second electrode contacts are electrically connected with each other, the first electrode contacts are electrically connected with each other, and only one electrical contact pairs in each connection line unit is connected with the light emitting diode chip; in each connection line unit, at least two first electrode contacts are arranged adjacent to each other, and at least two first electrode contacts are arranged between at least two second electrode contacts.

Abstract: A silica-based substrate includes a glass phase and a dispersed phase having carbon, such that the silica-based substrate has a thickness of at least 10 gm. Also disclosed is a method of forming a silica-based substrate, the method including contacting a porous silica soot preform with an organic solution having at least one hydrocarbon precursor to form a doped silica soot preform and heating the doped silica soot preform in an inert atmosphere to form the silica-based substrate.

Abstract: The present disclosure relates to vehicle technology, and more particularly, to a vehicle for carrying a container. The vehicle includes: a vehicle body, at least one locking mechanism provided on the vehicle body and a microcontroller unit communicatively connected to each of the at least one locking mechanism and configured to control each of the at least one locking mechanism to switch between a locked state and an unlocked state. Each of the at least one locking mechanism is connected fixedly to the container when the locking mechanism is in the locked state, such that the container is fixed to the vehicle body. The vehicle is advantageous in that it is capable of locking and unlocking the container in a simple way, thereby improving the efficiency of the vehicle in transportation of the container.

Abstract: A physiological detection device includes system including a first array PPG detector, a second array PPG detector, a display and a processing unit. The first array PPG detector is configured to generate a plurality of first PPG signals. The second array PPG detector is configured to generate a plurality of second PPG signals. The display is configured to show a detected result of the physiological detection system. The processing unit is configured to convert the plurality of first PPG signals and the plurality of second PPG signals to a first 3D energy distribution and a second 3D energy distribution, respectively, and control the display to show an alert message.

Abstract: There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutical acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Abstract: A display device include a first light emitting diode (LED), a second LED, and at least one processor of a driver. The processor drives the first LED and the second LED. The processor determines a first pulse width associated with the first LED and a second pulse width associated with the second LED based on a level of brightness to be emitted by the first LED and the second LED. The processor also receives a gap clock and determines a first pulse start time and a first pulse end time for the first LED based on the first pulse width. Moreover, the processor determines a second pulse start time and a second pulse end time for the second LED based on the first pulse end time, the second pulse width, and/or the gap clock, in which the first pulse end time and the second pulse end time are different.

Abstract: There is provided a peptide-containing compound that comprises a peptide component which is an amino acid sequence of from 2 to 45 (e.g. from 6 to 15) amino acids, which peptide component is covalently bonded to one or more compounds of the formula I: wherein: R1 is selected from the group consisting of —C(CH3)2OH, —COCH3, —C(CH3)?CH2 and —C(CH3)2H; and n is 0, 1 or 2, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide-containing compound. The compound of formula I is preferably montelukast, montelukast styrene or hydrogenated montelukast styrene. The peptide-containing compound is particularly useful in the treatment of conditions characterised by inflammation, including wounds, hemorrhoids, burns, psoriasis, acne, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, chronic obstructive pulmonary disease, inflammatory bowel disease (such as ulcerative colitis).

Abstract: Light emitting diode display panels with an open loop amplifier resulting in better brightness accuracy and matching between multiple light emitting diode strings.

Abstract: There is provided a compound of formula (I), A-Q-B I wherein Q represents a structural fragment of formula (II), wherein: the squiggly lines and m have meanings given in the description, and wherein A and B have meanings given in the description, but may represent a peptide component of the amino acid sequence: [W-Lys-X1-Ser-U—X2—Y]n—W-Lys-X1-Ser-U—X2—Y— (SEQ ID No: 3) wherein the dashed line, n, W, X1, U, X2 and Y have meanings given in the description, which compounds are useful in medicine, including as pharmaceutical excipients, adhesives and film-forming materials and/or are useful in the treatment of conditions characterised by inflammation, including wounds, burns, and disorders of the mucosa, such as anorectal diseases, inflammatory bowel diseases, gynaecological diseases and dental diseases.

Abstract: An integrated system for automatic forming, picking, and inspection of a grinding wheel mesh piece and a method thereof, including a visual inspection system (1), a conveying system (2), a cutting system (3), and a picking system (4); the conveying system (2) is used to precisely control a conveying action of a cutting section conveying platform (51) and a picking section conveying platform (52), and the visual inspection system (1) is used to acquire an image of a grinding wheel mesh cloth, establish virtual origin coordinates of a cutting layout and center coordinates of the grinding wheel mesh piece after cutting, recognize defects of the grinding wheel mesh cloth, and calibrate qualified center coordinates and unqualified center coordinates; the cutting system (3) is used to cut the grinding wheel mesh cloth moved to the cutting section conveying platform (51) to obtain a circular grinding wheel mesh piece.

Abstract: A semiconductor memory comprising: a comparison readout circuit comprising a first port configured to receive an electric signal of a read memory unit and a second port configured to receive a reference electric signal, the comparison readout circuit being configured to compare the electric signal of the read memory unit with the reference electric signal to obtain storage information of the memory unit; and a first/second column decoder connected to a first/second memory array and the comparison readout circuit and configured to select a bitline corresponding to the read memory unit when a memory array selection signal enables the first/second memory array, and output the electric signal of the memory unit to the first port by means of the bitline, and further configured to connect a first bitline of the first/second memory array to the second port when the memory array selection signal does not enable the first/second memory array.

Abstract: Systems and methods for preserving a pulse width modulation (PWM) resolution while increasing the frequency of a pulse width modulation (PWM) clock are provided. An electronic display backlight system may include a backlight element and backlight dimming circuitry. The backlight element may be driven according to a pulse width modulation (PWM) signal over a PWM clock cycle equal to a multiple M of a baseline PWM clock frequency associated with a baseline PWM resolution. The backlight dimming circuitry may receive a brightness code of the baseline PWM resolution and generate the PWM signal at least in part by dividing the brightness code by M.

Abstract: There is provided a peptide-containing compound that comprises a peptide component which is an amino acid sequence of from 2 to 45 (e.g. from 6 to 15) amino acids, which peptide component is covalently bonded to one or more compounds of formula I: wherein: R1 is selected from the group consisting of —C(CH3)2OH, —COCH3, —C(CH3)?CH2 and —C(CH3)2H; and n is 0, 1 or 2, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide-containing compound. The compound of formula I is preferably montelukast, montelukast styrene or hydrogenated montelukast styrene. The peptide-containing compound is particularly useful in the treatment of conditions characterised by inflammation, including wounds, hemorrhoids, burns, psoriasis, acne, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, chronic obstructive pulmonary disease, inflammatory bowel disease (such as ulcerative colitis).

Abstract: There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutical acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Abstract: A method and an apparatus related to network analysis are provided. A work topology is mapping into an abstract topology according to a workload's network behavior. The network behavior is defined by a connection of the workload via one or more ingress ports and/or one or more egress target ports. The work topology records one or more ingress ports or one or more egress target ports supported by the workload. The abstract topology records a dynamic relationship of the currently operating ingress port or egress target port of the workload and a corresponding anomaly rule. The dynamic relationship is compared with the anomaly rule to determine that an abnormal situation occurs on the workload. The abnormal situation is related to a violation of the workload model which comprises static role, dynamic relationship, and the anomaly rule. The dynamic relationship is an associated behavior between the workload and another workload via the ingress ports and/or the egress target ports of the workload.

Abstract: A semiconductor memory, comprising a negative voltage providing unit, which is used for providing a first negative voltage to a word line during a read operation, and comprises: a clamping unit that comprises an input end, a control end and an output end, wherein the input end is coupled to a common ground end of the memory, and the control end is used for receiving a first signal; an energy storage capacitor, a first end of which is coupled to the output end, and a second end that is used for receiving a second signal; and a negative voltage providing end which is coupled to the first end, wherein the clamping unit is used for: pulling the voltage at the output end to the voltage at the input end when the first signal is “0”; and clamping the output end at a clamping voltage when the first signal is “1”.

Abstract: Provided is a conjugate formed between one or more linear polysaccharide chains and a peptide selected from one or more of the peptide components (a), (b), (c) or (d) as defined below: (a) a peptide component of formula (I), A-Q-B I wherein Q represents a structural fragment of formula (II), wherein: the squiggly lines and m have meanings given in the description and A and B have meanings given in the description, but may represent a peptide component of the amino acid sequence: [W-Lys-X1-Ser-U-X2-Y] n-W-Lys-X1-Ser-U-X2-Y--- (SEQ ID No: 3), wherein the dashed line, n, W, X1, U, X2 and Y have meanings given in the description; (b) a peptide component of the amino acid sequence: [Ala-Lys-X1-Ser-U-X2-Y] p-Ala-Lys-X1-Ser-U-X1-Y-G (SEQ ID No: 4) wherein p, G, X1, U, X2 and Y have meanings given in the description; (c) a peptide component of the amino acid sequence: W-Lys-X1-Ser-U-X2-Y-G (SEQ ID No: 5), wherein W, X1, U, X2, Y and G have meanings given in the description; or (d) a peptide component of the amino aci